google_counter
background_img

St. Lukas Clinic Solingen

location_on Solingen, Germany
9/10 from 23 Votes

Department of Oncology and Hematology (303041)

Ulrich Mahlknecht

Prof. Dr. med.

Ulrich Mahlknecht

Specialized in: oncology, hematology

About the department

The Department of Oncology and Hematology at the St. Lukas Clinic Solingen offers the widest options of diagnostics and treatment of solid malignant tumors, as well as benign and malignant blood diseases. The comprehensive diagnostics is followed by the development of an optimal treatment regimen for each patient with due consideration of all his individual needs and wishes. The department's experienced specialists guarantee the professional performance of all modern treatment methods in accordance with the very latest scientific and medical standards. The department is headed by Prof. Dr. med. Ulrich Mahlknecht.

The department specializes in the diagnostics and treatment of gastrointestinal tumors, breast cancer, oral cavity and lung cancer, as well as rare solid malignancies. In addition, the scope of tasks of the department's doctors includes the treatment of myeloproliferative and myelodysplastic syndromes, leukemia, lymph node cancer, as well as other diseases of the bone marrow and immune system.

The department's experts have unique experience in the treatment of myelodysplastic syndrome (MDS). The St. Lukas Clinic Solingen in collaboration with the University of Heidelberg is the Center of Excellence for Myelodysplastic Syndrome. Thus, the department offers the very latest developments and the most effective treatment methods for patients with this diagnosis.

The department's service range includes the diagnostics and treatment of the following diseases:

  • Leukemias
  • Myeloproliferative syndrome
  • Myelodysplastic syndrome
  • Lymphomas (lymph node tumors)
  • Gastrointestinal cancer
  • Breast cancer
  • Oral cancer
  • Lung cancer
  • Hemodyscrasia
  • Blood-clotting disorders
  • Pathologies of the immune system
  • Other diseases

The therapeutic options of the department include:

  • Chemotherapy
  • Immunotherapy
  • Hormone therapy
  • Supportive treatment
  • Alternative medicine methods (including dietetics and evidence-based naturopathic methods)
  • Pain therapy
  • Palliative care
  • Psycho-oncological support
  • Other treatment methods

Curriculum vitae

Prof. Ulrich Mahlknecht studied Medicine at the Universities of Bochum, Birmingham, Paris and Tuebingen, where in 1995 he received his doctorate. The doctor began his training for board certification at the University of Freiburg. From 1996 to 1999, he was Postdoctoral Research Fellow at the Picower Institute for Medical Research of the State University of New York. From 1999 to 2003, he continued his professional training as Intern in the field of hematology and oncology at the Goethe University Frankfurt, where he had his habilitation in Internal Medicine. Since 2004, he worked as Senior Physician in the Department of Internal Medicine at the University Hospital Heidelberg. He also led the Medical Task Force on Myelodysplastic Syndrome (MDS) and Acute Leukemia here. At the same time, he headed the MDS Centers of Excellence in Heidelberg (also being the founder of this center).

Prof. Ulrich Mahlknecht is actively engaged in research activities. He participated in the study of molecular markers and the development of epigenetic and immunotherapeutic approaches to the treatment of acute leukemias and myelodysplastic syndrome as part of the Emmy Noether Programme of the German Research Foundation, funded by the Josep Carreras Leukaemia Research Institute. In 2007, Ulrich Mahlknecht was appointed as Professor at the Saarland University in the Department of Immunotherapy and Gene Therapy where he is engaged in research of new molecular therapies for the treatment of acute leukemia and myelodysplastic syndrome at the José Carreras Institute for Immunology and Gene Therapy. Prof. Mahlknecht is President of the Clinical Epigenetics Society, a nonprofit international association promoting clinical science and research in the field of clinical epigenetics, and the Founder of the Clinical Epigenetics scientific journal.

Since 2012 Dr. Mahlknecht has been heading the Department of Oncology and Hematology at the St. Lukas Clinic Solingen.

In May 2019, he received the U.S. Albert Nelson Marquis Lifetime Achievement Award for a lifelong commitment to healthcare and contribution to research and teaching.

Photo of the doctor: (c) St. Lukas Klinik GmbH

Department of Oncology and Hematology.
St. Lukas Clinic Solingen:

Request more information now.
We will be happy to answer all your questions.


Certificates

Need Help?

Thank you!

We received your treatment application in the best Europe clinics. Our manager will contact you within the next 24 hours.